Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103787942B reveals a scalable HWE reaction route for lubiprostone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Novel Rh-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates with AURKA inhibitory activity and scalable production capabilities.
Novel patent CN117342999A enables green synthesis of H3R modulators. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel sulfuric acid salification method ensures high purity 2-bromo-4-chloropyridine. Eliminates column chromatography for cost reduction in pharma manufacturing.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Patent CN102311440B details a novel 5-step synthesis for high-purity diazabicyclo octane intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105669517A reveals metal-free indole synthesis offering cost reduction in pharmaceutical intermediates manufacturing and high-purity indole compounds for global supply chains.
Patent CN101910148B reveals a novel crystallization process for dodecahydro-naphtho-furanyl-carbamate intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel patent CN104311536A details high-yield lenalidomide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Patent CN105693621A details a novel oxidative sulfonylation method using stable sulfinate salts, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Novel cyanation patent CN110437262A enables safer pharmaceutical intermediate manufacturing with reduced toxicity and improved supply chain reliability for global buyers.
Novel catalyst-free method for 1,3,5-triazines using sodium difluorochloroacetate. High yield, scalable process for pharmaceutical intermediates.
Patent CN112979665B details novel griseofulvin derivatives with potent antitumor activity via Schmidt rearrangement, offering cost-effective routes for API intermediates.
Novel copper-catalyzed route for cyclic amidines offering high stereocontrol and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN112390816B discloses a scalable synthesis of oxazepine derivatives for Hepatitis B treatment, offering improved yield and safety for API manufacturing.
Efficient Cu(OTf)2 catalyzed synthesis of quinazoline-4-amines via green one-pot tandem reaction. Reliable API intermediate supplier offering cost reduction.